Cargando…

Application Potential of CTHRC1 as a Diagnostic and Prognostic Indicator for Colon Adenocarcinoma

Colon adenocarcinoma (COAD), ranking third in incidence and second in mortality, is one of the most common cancer types in the world. The initial stages of COAD usually show no obvious clinical symptoms; moreover, effective screening or diagnostic indicators with high sensitivity and specificity are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Chen, Wang, Hongwei, Shen, Chengcheng, Liang, Houjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921526/ https://www.ncbi.nlm.nih.gov/pubmed/35300110 http://dx.doi.org/10.3389/fmolb.2022.849771

Ejemplares similares

Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
por: Jiang, Xiulin, et al.
Publicado: (2022)

Expression and Gene Regulation Network of Adenosine Receptor A2B in Lung Adenocarcinoma: A Potential Diagnostic and Prognostic Biomarker
por: Sui, Yutong, et al.
Publicado: (2021)

Prognostic Immunity and Therapeutic Sensitivity Analyses Based on Differential Genomic Instability-Associated LncRNAs in Left- and Right-Sided Colon Adenocarcinoma
por: Guo, Jun-Nan, et al.
Publicado: (2021)

Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Ma, Jiaxiu, et al.
Publicado: (2022)

SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
por: Cheng, Xin, et al.
Publicado: (2022)

LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers
por: Xiao, Junbo, et al.
Publicado: (2021)

Diagnostic and Prognostic Potential of Circulating and Tissue BATF2 in Nasopharyngeal Carcinoma
por: Cui, Zhaolei, et al.
Publicado: (2021)

PAXX, Not NHEJ1 Is an Independent Prognosticator in Colon Cancer
por: Arora, Mohit, et al.
Publicado: (2020)

Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms
por: Chi, Hao, et al.
Publicado: (2023)

Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode
por: Jiawei, Zhou, et al.
Publicado: (2020)

Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma
por: Meng, Yiming, et al.
Publicado: (2022)

Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma
por: Zhao, Zhiying, et al.
Publicado: (2022)

Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity
por: Zheng, Pengdou, et al.
Publicado: (2022)

SYDE1 Acts as an Oncogene in Glioma and has Diagnostic and Prognostic Values
por: Han, Zhenyuan, et al.
Publicado: (2021)

The Prognostic Model and Drug Sensitivity of LKB1-Mutant Lung Adenocarcinoma Based on Immune Landscape
por: Wang, Guanghui, et al.
Publicado: (2022)

LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
por: Jin, Xin, et al.
Publicado: (2021)

Analysis of the Prognostic Value and Gene Expression Mechanism of SHOX2 in Lung Adenocarcinoma
por: Li, Nanhong, et al.
Publicado: (2021)

Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

Integrated Analysis of Transcriptomic and Genomic Data Reveals Blood Biomarkers With Diagnostic and Prognostic Potential in Non-small Cell Lung Cancer
por: Kaya, Ibrahim H., et al.
Publicado: (2022)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma
por: Hong, Xiaoling, et al.
Publicado: (2023)

Diagnostic, Therapeutic, and Prognostic Value of the Thrombospondin Family in Gastric Cancer
por: Lu, Yi, et al.
Publicado: (2021)

Editorial: Methods and applications in molecular diagnostics
por: Arora, Naina, et al.
Publicado: (2023)

CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma
por: Huang, Huimin, et al.
Publicado: (2021)

Diaphanous-related formin subfamily: Novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma
por: Zhang, Bixi, et al.
Publicado: (2022)

Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
por: Dhama, Kuldeep, et al.
Publicado: (2019)

Prognostic Implications and Immune Infiltration Characteristics of Chromosomal Instability-Related Dysregulated CeRNA in Lung Adenocarcinoma
por: Guo, Shengnan, et al.
Publicado: (2022)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Immune-Related RNA-Binding Protein-Based Signature With Predictive and Prognostic Implications in Patients With Lung Adenocarcinoma
por: Xu, Lei, et al.
Publicado: (2022)

Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes
por: Huang, Xin, et al.
Publicado: (2023)

AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma
por: Fan, Dengxia, et al.
Publicado: (2023)

Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2021)

TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma
por: Xiao, Xinhua, et al.
Publicado: (2022)

Identification of TRP-Related Subtypes, Development of a Prognostic Model, and Characterization of Tumor Microenvironment Infiltration in Lung Adenocarcinoma
por: Sun, Sibo, et al.
Publicado: (2022)

Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma
por: Fan, Yuxiang, et al.
Publicado: (2021)

Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma
por: Lin, Xinqing, et al.
Publicado: (2020)

An artificial intelligence prediction model based on extracellular matrix proteins for the prognostic prediction and immunotherapeutic evaluation of ovarian serous adenocarcinoma
por: Geng, Tianxiang, et al.
Publicado: (2023)

Comprehensive Analysis Revealed the Potential Implications of m6A Regulators in Lung Adenocarcinoma
por: Xie, Lingling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jaavvorjpdbv848qobv398867h